Concomitant |
Product Used For Unknown Indication |
52.3% |
Drug Use For Unknown Indication |
11.0% |
Rheumatoid Arthritis |
6.0% |
Osteoporosis |
5.1% |
Prophylaxis |
4.3% |
Urinary Tract Infection |
2.9% |
Multiple Myeloma |
2.5% |
Depression |
1.9% |
Pain |
1.9% |
Hypertension |
1.8% |
Grand Mal Convulsion |
1.4% |
Chronic Lymphocytic Leukaemia |
1.2% |
Atrial Fibrillation |
1.1% |
Constipation |
1.1% |
Crohn's Disease |
1.0% |
Glaucoma |
1.0% |
Hiv Infection |
1.0% |
Anticoagulant Therapy |
0.8% |
Asthma |
0.8% |
Dyspepsia |
0.8% |
|
Urinary Tract Infection |
10.2% |
Loss Of Consciousness |
8.0% |
Unresponsive To Stimuli |
6.8% |
Hallucination, Visual |
5.7% |
Memory Impairment |
5.7% |
Myalgia |
5.7% |
Pneumonia |
5.7% |
Vomiting |
5.7% |
Liver Function Test Abnormal |
4.5% |
Pancreatitis |
4.5% |
Sepsis |
4.5% |
Visual Impairment |
4.5% |
White Blood Cell Count Decreased |
4.5% |
Blood Creatine Phosphokinase Increased |
3.4% |
Colitis Ulcerative |
3.4% |
Electrolyte Imbalance |
3.4% |
Gastritis |
3.4% |
Haematuria |
3.4% |
Haemoglobin Decreased |
3.4% |
Hallucination, Auditory |
3.4% |
|